These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11441687)

  • 1. Outpatient cervical ripening using a sustained-release prostaglandin E2 vaginal insert.
    Tassone SA; Pearman CR; Rayburn WF
    J Reprod Med; 2001 Jun; 46(6):599-600. PubMed ID: 11441687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Uterine hyperstimulation following cervix ripening with dinoprostone in a vaginal insert system].
    Brouwers JM; Briët JW; Brouwers JR
    Ned Tijdschr Geneeskd; 2004 Jun; 148(26):1300-3. PubMed ID: 15279216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical evaluation of controlled-release dinoprostone for cervical ripening--a review of current evidence in hospital and outpatient settings.
    Rath W
    J Perinat Med; 2005; 33(6):491-9. PubMed ID: 16318611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elective cervical ripening in women beyond the 290th day of pregnancy: a randomized trial comparing 2 dinoprostone preparations.
    Facchinetti F; Venturini P; Fazzio M; Volpe A
    J Reprod Med; 2007 Oct; 52(10):945-9. PubMed ID: 17977171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of the efficacy of dinoprostone slow release vaginal insert (Propess) for cervical ripening: A prospective cohort study.
    Daykan Y; Biron-Shental T; Navve D; Miller N; Bustan M; Sukenik-Halevy R
    J Obstet Gynaecol Res; 2018 Sep; 44(9):1739-1746. PubMed ID: 29978599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Uterine hyperstimulation following cervix ripening with dinoprostone in a vaginal insert system].
    Veerman HM
    Ned Tijdschr Geneeskd; 2005 Jan; 149(2):105-6; author reply 106. PubMed ID: 15688844
    [No Abstract]   [Full Text] [Related]  

  • 7. [An open evaluation of prolonged-release dinoprostone with a retrieval system (a formulation of 1.1 MM) in unfavorable cervical ripening in the induction of labor for medical and obstetrical indications].
    Moreno García JD; Márquez Becerra MA; Reyes Compain Ydel C; Juárez Azpilcueta AA
    Ginecol Obstet Mex; 1999 Jul; 67():302-7. PubMed ID: 10496051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducing labor with a sustained-release PGE2 vaginal insert. Experience at a community hospital.
    Blair FC; Tassone SA; Pearman CR; St Cyr MB; Rayburn WF
    J Reprod Med; 1998 May; 43(5):408-12. PubMed ID: 9610462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral misoprostol vs. intravaginal prostaglandin E2 for preinduction cervical ripening. A randomized trial.
    Gherman RB; Browning J; O'Boyle A; Goodwin TM
    J Reprod Med; 2001 Jul; 46(7):641-6. PubMed ID: 11499184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of vaginal prostaglandin E2 for induction of labor. Insert vs. tablet.
    Rabl M; Joura EA; Yücel Y; Egarter C
    J Reprod Med; 2002 Feb; 47(2):115-9. PubMed ID: 11883349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing two dinoprostone agents for cervical ripening and induction of labor: a randomized trial.
    Marconi AM; Bozzetti P; Morabito A; Pardi G
    Eur J Obstet Gynecol Reprod Biol; 2008 Jun; 138(2):135-40. PubMed ID: 17889983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dinoprostone Vaginal Insert: A Review in Cervical Ripening.
    Shirley M
    Drugs; 2018 Oct; 78(15):1615-1624. PubMed ID: 30317521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient misoprostol compared with dinoprostone gel for preinduction cervical ripening: a randomized controlled trial.
    Meyer M; Pflum J; Howard D
    Obstet Gynecol; 2005 Mar; 105(3):466-72. PubMed ID: 15738009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sweeping of membranes vs. intracervical prostaglandin E2 gel for cervical ripening. Randomized trial.
    Gemer O; Kapustian V; Harari D; Sassoon E; Segal S
    J Reprod Med; 2001 Aug; 46(8):706-8. PubMed ID: 11547642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological induction of labour: benefits and risks].
    Romanelli M; Ribiani E; Burnelli L; Luzi G; Affronti G; Di Renzo GC
    Minerva Ginecol; 2007 Aug; 59(4):347-55. PubMed ID: 17923826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of prostaglandin E2 gel and extra-amniotic saline infusion with high dose oxytocin for cervical ripening.
    Sharami SH; Milani F; Zahiri Z; Mansour-Ghanaei F
    Med Sci Monit; 2005 Aug; 11(8):CR381-6. PubMed ID: 16049380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Misoprostol vaginal insert compared with dinoprostone vaginal insert: a randomized controlled trial.
    Wing DA;
    Obstet Gynecol; 2008 Oct; 112(4):801-12. PubMed ID: 18827122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preinduction cervical ripening with prostaglandin E2 at preterm.
    Melamed N; Yogev Y; Hadar E; Hod M; Ben-Haroush A
    Acta Obstet Gynecol Scand; 2008; 87(1):63-7. PubMed ID: 18158629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma prostaglandin E(2) metabolite levels during labor induction with a sustained-release prostaglandin E(2) vaginal insert.
    Goharkhay N; Stanczyk FZ; Gentzschein E; Wing DA
    J Soc Gynecol Investig; 2000; 7(6):338-42. PubMed ID: 11111068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of intracervical versus posterior fornix dinoprostone for induction of labor.
    Perry MY; Leaphart WL
    Obstet Gynecol; 2004 Jan; 103(1):13-7. PubMed ID: 14704238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.